How MemoHoney works: the nitric oxide pathway, step by step
MemoHoney works by supplying nitric oxide precursors (L-Arginine and L-Citrulline in two forms each) that the body converts into nitric oxide, a molecule that relaxes blood vessel walls and supports normal circulation and oxygen delivery to the brain. Niacin adds NAD-dependent cellular energy support, while Beta-Alanine and Calcium contribute minor buffering and signalling roles. Effects are gradual and modest at the disclosed doses.
- 4 NO precursors
- Vasodilation mechanism
- Niacin → NAD energy
- Gradual, not acute

Step 1 — Precursors enter the bloodstream
After you swallow the capsule, L-Arginine is absorbed in the small intestine. A meaningful share of oral arginine is metabolised by the liver and gut wall before it reaches circulation (first-pass metabolism), which is why arginine on its own needs gram-level doses in studies. L-Citrulline bypasses that problem: it is absorbed largely intact, travels to the kidneys, and is converted into arginine there. This is the reason MemoHoney includes both amino acids in two forms each — it is a delivery strategy, not four separate mechanisms.
Step 2 — Arginine becomes nitric oxide
Inside the endothelial cells that line blood vessels, the enzyme endothelial nitric oxide synthase (eNOS) converts arginine into nitric oxide plus citrulline. Nitric oxide is a gas that diffuses into the neighbouring smooth muscle and triggers a cascade (cGMP) that relaxes the muscle. The vessel widens. This is vasodilation — the same fundamental pathway that nitrate heart medication and PDE5 inhibitors act on, which is why those combinations require medical supervision.
Step 3 — Blood flow and oxygen delivery
A relaxed vessel carries more blood at lower resistance. Systemically that supports normal circulation; locally it supports delivery of oxygen and glucose to tissue with high metabolic demand. The brain uses roughly 20% of the body's oxygen despite being about 2% of its mass, so it is the organ most sensitive to perfusion. This is the logic behind positioning a nitric oxide formula as brain support.
Step 4 — Cellular energy from niacin
Niacin (vitamin B3) is the precursor to NAD and NADP, coenzymes required in hundreds of reactions that turn food into ATP. MemoHoney supplies 7.5 mg NE — roughly half the adult daily requirement of 14–16 mg NE. This is the one ingredient where the dose is nutritionally meaningful. It is well below the 50 mg+ range where niacin flushing typically begins.
Supporting roles: Beta-Alanine and Calcium
Beta-Alanine is the rate-limiting precursor for carnosine, a molecule that buffers acid in muscle and has antioxidant activity. Research doses are 2,000–6,000 mg daily, loaded over several weeks; at 40 mg the contribution is minor. Calcium at 18 mg is under 2% of the daily requirement — a formulation footnote rather than a working ingredient.
What the disclosed doses mean for expectations
Here is the honest picture. The pathway is real and well characterised. The amounts that trigger measurable blood-flow changes in trials are 3,000 mg and above for arginine and citrulline; MemoHoney provides about 600 mg combined. That does not make the formula inert — nitric oxide production is dose-responsive rather than all-or-nothing — but it does mean you should expect gentle, cumulative support rather than the acute "pump" effect of a pre-workout. This is also why the manufacturer's own guidance is several weeks of consistent use.
Mechanism in one paragraph
- Citrulline → arginine (kidneys) → nitric oxide (eNOS) → vasodilation → circulation support.
- Niacin → NAD → cellular energy.
- Beta-Alanine and Calcium: minor supporting roles at these doses.
- Effect size is modest; timeline is weeks, not hours.
Frequently asked questions
No. Unlike caffeine, it has no acute stimulant effect. Users typically describe changes after four to eight weeks of daily use.
Citrulline avoids the liver's first-pass breakdown of arginine and converts to arginine in the kidneys, so the pair delivers the pathway more efficiently than arginine alone.
Yes, in principle — nitric oxide is a vasodilator. The effect at 600 mg is expected to be small, but anyone on blood pressure medication, nitrates or PDE5 inhibitors should consult a doctor first.
No finished-product trial has been published. The evidence base is ingredient-level research, generally at higher doses.